These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35080298)

  • 1. Novel artful applications of vaccines at the horizon.
    Montin D; Ottaviano G; Sangerardi M; Sgrulletti M; Chini L; Dellepiane RM; Martire B; Rizzo C; Moschese V
    Pediatr Allergy Immunol; 2022 Jan; 33 Suppl 27(Suppl 27):83-85. PubMed ID: 35080298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacillus Calmette-Guerin Vaccine and Nonspecific Immunity.
    Parmar K; Siddiqui A; Nugent K
    Am J Med Sci; 2021 Jun; 361(6):683-689. PubMed ID: 33705721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stopping live vaccines after disease eradication may increase mortality.
    Aaby P; Benn CS
    Vaccine; 2020 Jan; 38(1):10-14. PubMed ID: 31648913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-specific effects of vaccines: Current evidence and potential implications.
    de Bree LCJ; Koeken VACM; Joosten LAB; Aaby P; Benn CS; van Crevel R; Netea MG
    Semin Immunol; 2018 Oct; 39():35-43. PubMed ID: 30007489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trained immunity: implications for vaccination.
    Geckin B; Konstantin Föhse F; Domínguez-Andrés J; Netea MG
    Curr Opin Immunol; 2022 Aug; 77():102190. PubMed ID: 35597182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonspecific effects of vaccines and the reduction of mortality in children.
    Shann F
    Clin Ther; 2013 Feb; 35(2):109-14. PubMed ID: 23375475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The heterologous (non-specific) effects of vaccines: implications for policy in high-mortality countries.
    Shann F
    Trans R Soc Trop Med Hyg; 2015 Jan; 109(1):5-8. PubMed ID: 25573104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repurposing of the childhood vaccines: could we train the immune system against the SARS-CoV-2.
    Sharma D
    Expert Rev Vaccines; 2021 Sep; 20(9):1051-1057. PubMed ID: 34313516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-specific effects of BCG vaccine on viral infections.
    Moorlag SJCFM; Arts RJW; van Crevel R; Netea MG
    Clin Microbiol Infect; 2019 Dec; 25(12):1473-1478. PubMed ID: 31055165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leveraging Beneficial Off-Target Effects of Live-Attenuated Rotavirus Vaccines.
    Benedicto-Matambo P; Bines JE; Malamba-Banda C; Shawa IT; Barnes K; Kamng'ona AW; Hungerford D; Jambo KC; Iturriza-Gomara M; Cunliffe NA; Flanagan KL; Jere KC
    Vaccines (Basel); 2022 Mar; 10(3):. PubMed ID: 35335050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developing the concept of beneficial non-specific effect of live vaccines with epidemiological studies.
    Aaby P; Benn CS
    Clin Microbiol Infect; 2019 Dec; 25(12):1459-1467. PubMed ID: 31449870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are BCG-induced non-specific effects adequate to provide protection against COVID-19?
    Vashishtha VM
    Hum Vaccin Immunother; 2021 Jan; 17(1):88-91. PubMed ID: 32762516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of BCG, DTP, and measles containing vaccines with childhood mortality: systematic review.
    Higgins JP; Soares-Weiser K; López-López JA; Kakourou A; Chaplin K; Christensen H; Martin NK; Sterne JA; Reingold AL
    BMJ; 2016 Oct; 355():i5170. PubMed ID: 27737834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural and trained innate immunity against Mycobacterium tuberculosis.
    Ferluga J; Yasmin H; Al-Ahdal MN; Bhakta S; Kishore U
    Immunobiology; 2020 May; 225(3):151951. PubMed ID: 32423788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stopping Oral Polio Vaccine (OPV) After Defeating Poliomyelitis in Low- and Middle-Income Countries: Harmful Unintended Consequences? Review of the Nonspecific Effects of OPV.
    Aaby P; Nielsen S; Fisker AB; Pedersen LM; Welaga P; Hanifi SMA; Martins CL; Rodrigues A; Chumakov K; Benn CS
    Open Forum Infect Dis; 2022 Aug; 9(8):ofac340. PubMed ID: 35937644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuberculosis vaccine BCG: the magical effect of the old vaccine in the fight against the COVID-19 pandemic.
    Aspatwar A; Gong W; Wang S; Wu X; Parkkila S
    Int Rev Immunol; 2022; 41(2):283-296. PubMed ID: 33960271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacillus Calmette-Guerin (BCG): the adroit vaccine.
    Adesanya OA; Uche-Orji CI; Adedeji YA; Joshua JI; Adesola AA; Chukwudike CJ
    AIMS Microbiol; 2021; 7(1):96-113. PubMed ID: 33659771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lessons from Bacillus Calmette-Guérin: Harnessing Trained Immunity for Vaccine Development.
    Pasco ST; Anguita J
    Cells; 2020 Sep; 9(9):. PubMed ID: 32948003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-administration of live measles and yellow fever vaccines and inactivated pentavalent vaccines is associated with increased mortality compared with measles and yellow fever vaccines only. An observational study from Guinea-Bissau.
    Fisker AB; Ravn H; Rodrigues A; Østergaard MD; Bale C; Benn CS; Aaby P
    Vaccine; 2014 Jan; 32(5):598-605. PubMed ID: 24325827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential role of Bacillus Calmette-Guérin (BCG) vaccination in COVID-19 pandemic mortality: Epidemiological and Immunological aspects.
    Charoenlap S; Piromsopa K; Charoenlap C
    Asian Pac J Allergy Immunol; 2020 Sep; 38(3):150-161. PubMed ID: 32686943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.